38,986 Axon Enterprise, Inc $AXON Shares Purchased by International Assets Investment Management LLC

Key Points

• International Assets Investment Management LLC increased its Axon Enterprise stake by 38,986 shares, or 3,844.8%, during the third quarter, bringing its holdings to 40,000 shares valued at approximately $16.9 million. Institutional investors collectively own 79.08% of the company.
• Analysts maintain a generally positive outlook, with 14 Buy ratings, one Strong Buy, and two Holds. The consensus rating is Moderate Buy, with an average price target of $688.38, though individual targets range widely.
• AXON shares opened at $427.77, down 2.3%, while the company continues to show strong operating growth: quarterly revenue rose 35.3% year over year to $904.39 million and earnings exceeded estimates. However, its elevated valuation and recent insider selling could increase volatility.

International Assets Investment Management LLC raised its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 3,844.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,000 shares of the biotechnology company's stock after acquiring an additional 38,986 shares during the period. International Assets Investment Management LLC's holdings in Axon Enterprise were worth $16,901,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of AXON. State Street Corp grew its stake in shares of Axon Enterprise by 5,700.2% during the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company's stock worth $119,724,905,000 after acquiring an additional 209,879,882 shares during the period. Envestnet Asset Management Inc. lifted its holdings in Axon Enterprise by 18,050.2% during the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company's stock valued at $7,400,094,000 after purchasing an additional 13,127,348 shares during the last quarter. BlackRock Inc. lifted its holdings in Axon Enterprise by 4.3% during the second quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company's stock valued at $4,672,432,000 after purchasing an additional 345,365 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its holdings in Axon Enterprise by 391,214.9% during the third quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company's stock valued at $2,952,943,000 after purchasing an additional 6,987,098 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its position in Axon Enterprise by 8,432.6% during the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company's stock worth $1,983,414,000 after purchasing an additional 3,496,493 shares during the period. Hedge funds and other institutional investors own 79.08% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on AXON shares. Barclays lifted their target price on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an "overweight" rating in a research note on Thursday, August 6th. UBS Group upped their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a "neutral" rating in a research note on Thursday, August 6th. Morgan Stanley upped their price target on shares of Axon Enterprise from $600.00 to $640.00 and gave the company an "overweight" rating in a research note on Thursday, August 6th. Piper Sandler cut their price objective on shares of Axon Enterprise from $732.00 to $561.00 and set an "overweight" rating for the company in a report on Tuesday, October 20th. Finally, Northcoast Research boosted their target price on shares of Axon Enterprise from $650.00 to $680.00 and gave the company a "buy" rating in a report on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $688.38.

Insider Activity

In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of the firm's stock in a transaction on Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the completion of the transaction, the insider directly owned 56,264 shares of the company's stock, valued at $27,032,038.80. This trade represents a 1.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of the firm's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the transaction, the insider directly owned 97,761 shares of the company's stock, valued at approximately $61,266,818.70. The trade was a 8.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 47,397 shares of company stock valued at $26,722,984. 4.20% of the stock is owned by company insiders.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: An analyst opinion upgraded Axon Enterprise to “Buy,” arguing that the company’s valuation premium has narrowed and that its integrated public-safety hardware and cloud-software ecosystem continues to support strong growth. Axon Enterprise: Upgrading To Buy As The Premium Fades
• Positive Sentiment: Recent comparisons with DocuSign, Adobe and Datadog highlighted Axon’s rapid expansion in public safety and its combination of connected devices, software and recurring services. Other coverage also raised the possibility of substantial long-term upside, though these articles were opinion-based rather than new company announcements. Can Axon Stock Jump 50?
• Neutral Sentiment: Investment comparisons positioned Axon as a high-growth public-safety technology company, but offered no new financial results, contracts or guidance that would immediately change earnings expectations. Axon Enterprise vs. DocuSign
• Negative Sentiment: Investors may be reducing exposure before earnings because Zacks said Axon does not appear to have the usual combination of factors supporting a likely earnings beat. That raises the risk of volatility if results or guidance fall short of expectations. Axon Reports Next Week
• Negative Sentiment: Concerns remain that employee share-based compensation taxes are consuming cash despite strong growth, while the stock’s premium valuation leaves limited room for execution errors. Strong Growth, But Staff Share Taxes Eat The Cash
• Negative Sentiment: Axon’s larger decline than the broader market indicates near-term selling pressure, likely reflecting profit-taking and pre-earnings caution rather than a newly announced operational setback. Axon Registers a Bigger Fall Than the Market

Axon Enterprise Stock Down 2.3%

AXON stock opened at $427.77 on Friday. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The firm has a market capitalization of $34.75 billion, a PE ratio of 177.50, a PEG ratio of 8.13 and a beta of 1.44. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $749.96. The stock has a 50-day simple moving average of $463.44 and a two-hundred day simple moving average of $481.21.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.04. The firm had revenue of $904.39 million for the quarter, compared to analysts' expectations of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The company's revenue was up 35.3% on a year-over-year basis. During the same period in the prior year, the business posted $2.12 earnings per share. On average, equities analysts predict that Axon Enterprise, Inc will post 2.10 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company's portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.